Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 4, 2001, Pages 1238-1243

  Aldridge, K E ^a   Ashcraft, D ^a   Cambre, K ^a   Pierson, C L ^a   Jenkins, S G ^a   Rosenblatt, J E ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TROVAFLOXACIN;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; CONTROLLED STUDY; FUSOBACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; SPECIES DIFFERENCE;

BACTERIAL INFECTIONS; BACTEROIDES FRAGILIS; DRUG RESISTANCE, MICROBIAL; FUSOBACTERIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTOSTREPTOCOCCUS; PORPHYROMONAS; PREVOTELLA; SPECIES SPECIFICITY;

EID: 0035080986     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.4.1238-1243.2001     Document Type: Article

References (25)

1. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria
2. The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections
3. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamycins, penicillins, clindamycin, and metronidazole in the United States
4. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: A 4-year study
5. Conjugal transfer of imipenem resistance in Bacteroides fragilis
6. Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinero, quinupristin-dalfopristin) against Bacteroides fragilis group: Comparison with the activities of 14 other agents
7. Plasmid and non-plasmid mediated reduced sensitivity to metronidazole in the Bacteroides fragilis group
8. Transfer of β-lactamase-associated cefoxitin resistance in Bacteroides fragilis
9. β-lactamase production and antimicrobial susceptibility of oral heterogenous Fusobacterium nucleatum populations in young children
10. Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada
11. Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa
12. Transferable plasmid-linked chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis
13. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy
14. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: Findings of a multicenter prospective observational trial
15. High prevalence of resistance to clindamycin in Bacteroides fragilis group isolates
16. Attributable mortality of bacteremia associated with the Bacteroides fragilis group
17. Bacteroides species highly resistant to metronidazole: An emerging clinical problem?
18. Transferable tetracycline resistance in Clostridium difficile
19. Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of Bacteroides fragilis group: Effect of the medium on test results
20. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996
21. Plasmid-mediated transferable resistance to clindamycin and erythromycin in Bacteroides fragilis